# DESCRIPTION

## STATEMENT OF GOVERNMENT INTEREST

- acknowledge government support

## BACKGROUND

- motivate metastasis research
- introduce chloride channels
- discuss GABA receptors
- highlight ADAR and A-to-I RNA editing

## SUMMARY OF THE INVENTION

- introduce diagnostic composition
- describe detection methods
- outline treatment methods

## DETAILED DESCRIPTION OF THE INVENTION

- demonstrate correlation of GABRA3 with breast cancer survival and its role in cell migration, invasion, and metastasis

### I. GENERAL

- define technical and scientific terms
- provide definitions for clarity
- define "a" or "an"
- define "about"
- define "patient" or "subject"
- define "control" or "control subject"
- define "any intervening amount"
- define "sample"
- define "microarray"
- define "ligand", "polynucleotide", "oligonucleotide", "antibody", and "labels"

### II. DIAGNOSTIC COMPOSITIONS

- provide diagnostic compositions for breast cancer detection
- describe ligands that complex with GABRA3 or its mRNA
- describe polynucleotide or oligonucleotide ligands
- describe protein or peptide ligands
- describe antibody or fragment ligands
- describe labels and detection methods
- describe primer sets for identifying and/or amplifying GABRA3
- describe reagents and kits for GABRA3 detection

### II. DIAGNOSTIC METHODS

- provide diagnostic methods for breast cancer
- motivate GABRA3 as biomarker
- describe detection methods for GABRA3
- introduce protein assays for GABRA3 detection
- introduce nucleic acid assays for GABRA3 detection
- describe PCR-based methods for GABRA3 mRNA detection
- motivate A-to-I RNA editing of GABRA3
- describe quantification of A-to-I edited GABRA3
- outline diagnostic reagent selection and detection

### II. TREATMENT METHODS

- provide methods of treating breast cancer
- inhibit action of GABA in subject
- treat subject with GABAA receptor antagonist
- reduce level of expression or activity of GABRA3
- detect presence or measure level of GABRA3 in biological sample
- treat subject with reagent that inhibits action of GABA
- describe GABAA receptor antagonists
- provide dosages and treatment regimens
- administer GABAA receptor antagonist prior to or during chemotherapy or radiation
- administer GABAA receptor antagonist prior to or during surgery
- administer GABAA receptor antagonist after surgery
- determine dosage required for GABAA receptor antagonists
- administer GABAA receptor antagonist in combination with other pharmaceutical agents
- describe therapeutic compositions administered by methods
- provide routes of administration
- screen molecules for use in cancer therapy
- inhibit, suppress or down-regulate expression or overexpression of GABRA3
- administer reagent that binds to or interacts with GABRA3
- provide use of composition comprising reagent that decreases GABRA3 levels or inhibits action of GABA

### II. EXAMPLES

- introduce examples of the invention
- describe metastasis in breast cancer
- perform bioinformatics analysis using TCGA breast cancer data
- identify 41 genes associated with breast cancer survival
- describe GABRA3 expression in breast cancer cells
- introduce lentivirus transfection and transduction
- describe mammary fat pad injections
- perform transwell migration and invasion assay
- describe RNA isolation, reverse transcription, and real-time PCR analysis
- perform western blotting
- describe flow cytometry
- analyze RNA editing of GABRA3
- identify GABRA3 in breast cancer progression
- describe GABRA3 expression in normal human tissues
- analyze GABRA3 expression in human breast cancer cell lines
- describe GABRA3 expression in paired human breast cancer samples
- analyze TCGA survival data
- introduce GABRA3 into human breast cancer MCF7 cells
- assess GABRA3 contribution to cell migration and invasion
- measure metastasis-promoting activity of GABRA3 in vivo
- introduce short hairpin RNA constructs into human breast cancer MDA-MB-436 cells
- discuss treatment of breast cancer cells with GABRA3 inhibitors

